BADALAMENTI, PHARMD, V. C.; BUCKLEY, PHARMD, J. W.; SMITH, PHARMD, E. T. Safety of EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release capsules: Review of postmarketing adverse events during the first year. Journal of Opioid Management, [S. l.], v. 8, n. 2, p. 115–125, 2012. DOI: 10.5055/jom.2012.0104. Disponível em: https://wmpllc.org/ojs/index.php/jom/article/view/780. Acesso em: 21 nov. 2024.